Published by ChinaMNC · Wenshan

Yunnan’s 15th Five-Year Plan for Chinese Medicinal Herbs: What Foreign Founders Need to Know

Yunnan plans to shrink herb planting area while raising output value, expand GAP bases and under-forest cultivation, and support processing, health products, standards and AI under its 15th Five-Year Plan for the Chinese medicinal herb industry.

Yunnan’s New Direction for Chinese Medicinal Herbs

Yunnan Province has published a plan for the Chinese medicinal herb industry covering the 15th Five-Year Plan period. For foreign founders considering a China company in herbal cultivation, processing, health products or related services, the document sets out where provincial support is expected to focus through 2030.

The headline targets are a reduction in planting area and an increase in value. By 2030, the province expects herb planting area to fall by 1.608 million mu, while the comprehensive output value target rises by 50 billion yuan. The stated logic is to trade area for gains in quality, processing, branding and efficiency. Founders should read this as a signal that expansion of low-value planting is not the priority; higher-value activities are.

Which Varieties Are Prioritised

The plan builds on the 156 varieties listed in the 2024 Yunnan Catalogue of Dao-di Herbs. It identifies three groups:

• Dao-di advantage varieties: the “Top Ten Yunnan Herbs”, represented by Panax notoginseng, together with Paris polyphylla var. yunnanensis, Erigeron breviscapus, Dendrobium officinale, Amomum villosum, Gastrodia elata, Yunnan Poria, Yunnan Angelica sinensis, Yunnan Aucklandia and Yunnan Gentiana.
• Health-characteristic varieties: the “Top Ten Health Resources”, namely Polygonatum kingianum, safflower, Bletilla striata, purple-skinned Dendrobium, Phyllanthus emblica, Coix seed, Terminalia chebula, Amomum tsaoko, ginger and star anise.
• Potential varieties: the “Six Southern Medicines”, namely Amomum villosum, dragon’s blood, Cibotium barometz, agarwood, Orthosiphon aristatus and Dai Bai Jie.

For founders, the variety lists are a useful guide to where research, sourcing and product development may align with provincial priorities. They are not an approval list, and any cultivation or product activity still requires its own compliance checks.

Standardised Cultivation and GAP Bases

Yunnan aims to build 200 Chinese medicinal herb GAP bases. The plan gives priority to full GAP coverage for Wenshan Panax notoginseng, and to orderly development of GAP bases for under-forest varieties including Poria, Amomum villosum, Amomum tsaoko and Phellodendron. It also aims to create a group of national-level high-standard raw material production bases.

A foreign founder looking at upstream operations should note that GAP base development is framed as a provincial priority. The plan does not set out foreign investment rules, land procedures or approval requirements, so these must be checked separately with the relevant authorities.

Under-Forest Cultivation

The plan focuses on dao-di herbs such as Panax notoginseng, Gastrodia elata, Poria, Amomum villosum, Polygonatum and Phellodendron. It calls for vigorous development of under-forest herb cultivation and breeding, with ecological and under-forest planting bases expanded to more than six million mu.

This is relevant to founders exploring cultivation models that combine forestry and herbs. The source presents the target as a provincial aim; it does not provide investor eligibility criteria or land-use approvals.

Origin Processing and Higher-Value Products

The plan supports establishing processing lines at origin in dao-di herb production areas and high-standard raw material bases. It also seeks to link GAP-base herbs with fresh cutting, and to upgrade products from primary raw materials to semi-industrial input materials.

Further support is directed at enterprises building modern deep-processing lines and developing high-value-added products, forming a series of Yunnan herb health products. The plan also promotes research, development and industrialisation of health products such as daily chemical and beauty products and functional wellness products.

For foreign founders, these sections point to processing and product development as areas the province intends to encourage. The source does not specify incentives, subsidies or foreign ownership conditions.

Market Stability and Risk Monitoring

The plan addresses market volatility for major and scarce varieties such as Panax notoginseng, Angelica sinensis and Paris polyphylla. It proposes market-based adjustment to smooth fluctuations and an information monitoring and early-warning system to guard against risks such as blind expansion of planting and prices falling enough to hurt farmers.

Founders planning sourcing or contract farming should note that provincial attention to supply volatility is explicit. The document does not create price guarantees or supply commitments.

Food-Medicine Homology and Cross-Border Registration

Yunnan plans to formulate standards for food-medicine homologous raw materials, including quality standards and production and processing specifications. It also aims to complete cross-border registration and launch of five to ten new products, and to plan a “Yunnan Herb Food-Medicine Homology Culture Festival”.

Cross-border registration is a practical area for founders with regional ambitions, but the source gives only the target number and does not describe procedures or eligible product categories.

“Yunnan Herb Brain” and AI

The plan includes a “Yunnan Herb Brain” artificial intelligence innovation application project. It aims to build an intelligent application system covering the full life cycle of Chinese medicinal herbs, and to develop multi-level, multi-scenario intelligent solutions in key areas.

This may interest founders in agritech, traceability or data services. The source describes the project as a provincial initiative and does not set out procurement or partnership processes.

Practical Takeaways for Foreign Founders

Overall, the plan signals a shift from area expansion toward quality, standardised bases, processing depth, product development and digital tools. Founders should treat the targets as policy direction rather than commercial guarantees. Company registration, land use, licensing, product registration and tax treatment must be verified with the competent authorities and professional advisers.

This summary is based on information published by the relevant Chinese government website and is general information, not legal or tax advice.